GeneDx Holdings (WGS) Short term Debt (2020 - 2023)

GeneDx Holdings (WGS) has 4 years of Short term Debt data on file, last reported at $4.3 million in Q1 2023.

• Short term Debt for Q1 2023 came in at $4.3 million, up 33.3% year-over-year; the trailing twelve-month figure through Mar 2023 was $4.3 million (up 33.3% YoY), and the FY2022 annual result was $3.6 million, up 36.98% from the prior year.
• Short term Debt climbed to $4.3 million in Q1 2023 per WGS's latest filing, from $3.6 million in the prior quarter.
• Over five years, Short term Debt peaked at $4.3 million in Q1 2023 and troughed at $797000.0 in Q1 2021.
• A 4-year average of $2.3 million and a median of $2.1 million in 2022 frame the typical range for Short term Debt.
• On a YoY basis, Short term Debt climbed as much as 306.15% in 2022 and fell as far as 28.28% in 2022.
• A 4-year view of Short term Debt shows it stood at $1.4 million in 2020, then surged by 84.07% to $2.6 million in 2021, then surged by 36.98% to $3.6 million in 2022, then advanced by 20.09% to $4.3 million in 2023.
• Business Quant data shows WGS's Short term Debt at $4.3 million in Q1 2023, $3.6 million in Q4 2022, and $1.8 million in Q3 2022.